By Heidi Ledford of Nature magazine Potential cancer treatments are loitering in the wings as clinical trials are delayed by widespread shortages of common chemotherapy drugs. The I-SPY 2 Breast Cancer Clinical Trial, for example, a high-profile experiment aiming to test the use of certain molecular markers to guide cancer treatment, was designed to allow researchers to adapt the study's protocol in response to early results. [More]
Continued here:
Drug shortage slows clinical trials
If you enjoyed this post, make sure you subscribe to my RSS feed!